Make a difference for your RA patients with CIMZIA
CIMZIA is indicated for the treatment of adults with moderately to severely active RA.1
Time to choose a different PsA biologic? Choose CIMZIA.
CIMZIA is indicated for the treatment of adult patients with active PsA.1
Discover a treatment option for your patients with AS
CIMZIA is indicated for the treatment of adults with active AS.1
Non-radiographic Axial Spondyloarthritis
Meet the challenge of managing nr-axSpA with CIMZIA, the ONLY FDA-approved TNFi for this condition
CIMZIA is indicated for the treatment of adults with active nr-axSpA with objective signs of inflammation.1
TNFi: tumor necrosis factor inhibitor.
CIMplicity can help provide ongoing support for your patients throughout their journey.
The CIMplicity program is provided as a service of UCB and is intended to support the appropriate use of CIMZIA. The CIMplicity program may be amended or canceled at any time without notice. Some program and eligibility restrictions may apply.